A variety of factors should inform your device marketing strategy.
It’s becoming more and more difficult for Western companies to make their way into this competitive market.
The market is being driven by smaller components, wireless technology and new control systems.
CDRH is urging the development of medical technologies and diagnostic tests that address pain, addiction and diversion.
Here’s a hint: Compliance with new regulation in Europe is a high priority.
When FDA says stop, they mean stop!
Although pharmaceuticals are the main treatment route, medical devices are needed to fight the disease on a new level.
The need is growing for life-saving treatments.
In the quest for faster, more accurate results, these products will have a tremendous impact on diagnosing infectious diseases.
Changes in financial reporting can be an annual disruption for medical device companies. But the impact of recent changes to financial accounting standards is likely the most sweeping since the passage of the Sarbanes Oxley Act of 2002.